EAST HARTFORD, CT — BioSafe Systems is pleased to announce preliminary results from a GLP efficacy study demonstrated that SaniDate All Purpose Disinfectant is an effective virucide against Human Coronavirus on hard, non-porous surfaces. SaniDate All Purpose Disinfectant met the performance requirements under the test conditions for virucidal efficacy as set by EPA. The efficacy study was conducted using the product at a rate of 3.0 fl. oz. per gallon with a 10-minute contact time. SaniDate All Purpose Disinfectant demonstrated total inactivation of the virus, a ≥4.00 log10 reduction in titer of Human Coronavirus. US EPA requires a minimum ≥3.00 log10 reduction in titer for approval.
With these positive results, the virucidal study will be submitted to United States EPA for evaluation and approval with a label amendment to add virucidal Human Coronavirus claims through an expedited process. Once approved, this virus will be added to the product label in the United States* allowing the product to be included in the EPA List N-Disinfectants for Use Against SARS-CoV-2.
SaniDate All Purpose Disinfectant (U.S. EPA Reg. No. 70299-27) is a hydrogen peroxide and peroxyacetic acid-based one-step disinfectant cleaner for hard, non-porous surfaces. This product is formulated as a bleach alternative for use within medical facilities, childcare, schools, and at home. SaniDate All Purpose Disinfectant controls mold, mildew, and bacteria (Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella enterica) on contact.
*Registration is pending in Canada. Product review is currently underway with Health Canada and once approved, SaniDate All Purpose Disinfectant will be added to Health Canada Disinfectants for Use Against SARS-CoV-2 (COVID-19) List.